FWM
PRME icon

FSA Wealth Management’s Prime Medicine PRME Stock Holding History

FSA Wealth Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.31K Buy
+1,500
New +$6.09K ﹤0.01% 330

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

FSA Wealth Management's PRME Position: Q3 2025 in Review

FSA Wealth Management opened a new position in Prime Medicine (PRME) in Q3 2025: 1,500 shares worth $8.31K. The stake represents ﹤0.01% of the portfolio and ranks #330 among its holdings.

167 funds tracked by Wall St. Rank hold PRME as of Q3 2025.

  • FSA Wealth Management held 1,500 shares of Prime Medicine worth $8.31K as of Q3 2025.
  • Prime Medicine was a new FSA Wealth Management position in Q3 2025.
  • Prime Medicine made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #330 holding.
  • 167 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.